drug
iron
updated 3mo agoby Sri Devaraj Urs Academy of Higher Education and Research
community read0 votes
🐶 often sniffed alongside
top 8- tagApproval56 co-mentions · 29 sources
- drugsuccharated ferric oxide33 co-mentions · 30 sources
- drugIRON SUCROSE33 co-mentions · 30 sources
- tagRecall10 co-mentions · 6 sources
- companyAmerican Regent Inc8 co-mentions · 3 sources
- drugRNS-604 co-mentions · 2 sources
- company$FMSFresenius Medical Care AG4 co-mentions · 2 sources
- company$FMCQFFresenius Medical Care AG4 co-mentions · 2 sources
all catalysts(1)
Trials studying iron
- N/ADecoding the Neural Mechanisms Underlying Postural Instability and Gait Dysfunction in Parkinson's Disease
- phase4Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure
- N/AHypoferritinemia Without Anemia Among Reproductive Age Females
- EP1A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults.
- phase2Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- phase3A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
- N/AImproving Iron Levels in Female Endurance, Intermittent, and Power/Strength Athletes Aged 16-35
- phase3A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
News(10)
- Zealand sells milestone, royalty rights to rare blood cancer asset for up to $100MThe terms of the agreement with Royalty Pharma suggest the market potential of Zealand Pharma’s polycythemia vera drug candidate may be undervalued, according to Jefferies analysts.biospace · 7d ago
- Zealand sells its rights to Takeda’s blood cancer drug for $100M ahead of FDA approval decisionAs the FDA mulls whether to approve Takeda and Protagonist Therapeutics’ rusfertide, Zealand Pharma has sold its own rights to the blood cancer drug in return for $100 million.fiercebiotech · 8d ago
- Vaderis fuels up with $152M series B to test rare vascular disease in Phase 3Vaderis is hoping that engasertib will become the first approved medicine for hereditary hemorrhagic telangiectasia, a rare condition that can cause spontaneous bleeding.biospace · 9d ago
- After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’With the post-IPO quiet period having come to an end, CEO Benny Sørensen, M.D., Ph.D., was free to sit down with Fierce to map out Hemab’s future.fiercebiotech · 9d ago
- Silence brings the noise to Takeda with phase 2 blood cancer winA phase 2 trial of Silence Therapeutics’ divesiran has hit its primary endpoint, emboldening the biotech to gear up for late-phase development of a potential challenger to Takeda and Protagonist Th…fiercebiotech · 11d ago
- Syphilis spreads while researchers contend with federal constraints and a drug shortageAt the San Diego-Tijuana border, syphilis spreads while researchers contend with federal constraints and a drug shortage.stat · 20d ago
- Biogen validated the Alzheimer’s tau theory. CEO Viehbacher still isn’t betting the storeWith so many unknowns, Biogen is carefully eyeing its next-gen Alzheimer’s treatment diranersen as a high-risk, high-reward project with the potential for a major payout around 2030.biospace · 22d ago
- ‘Reverse mergers are increasingly popular’: Caldera hops on Synlogic’s Nasdaq listingCaldera Therapeutics has struck a reverse merger with the publicly traded Synlogic and inked a $278 million financing deal, continuing the meteoric rise of the inflammatory bowel disease startup.fiercebiotech · 22d ago
- After PCOS became PMOS, there’s hope for new awareness among Black and Latina womenGrowing awareness of a painful endocrine disorder now named PMOS is good news for women of color, who have high prevalence and low diagnosis.stat · 23d ago
- Opinion: E-bikes, e-scooters are a burgeoning pediatric public health emergency“Emergency departments across America report dramatic increases in serious injuries from e-bikes and e-scooters,” write CHOP’s J. Todd R. Lawrence and Madison A. Kesler.stat · 24d ago
Data sources
last refreshed 39m ago
Found something off?
comments(0)
5-min edit window · permanent after that